蘇馬尼羅
臨床資料 | |
---|---|
其他名稱 | PNU-95,666 |
ATC碼 |
|
識別資訊 | |
| |
CAS號 | 179386-43-7( 179386-44-8 (maleate)) |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C11H13N3O |
摩爾質量 | 203.25 g·mol−1 |
3D模型(JSmol) | |
|
蘇馬尼羅(英語:Sumanirole,研發代號:PNU-95,666)是一種有機化合物,化學式C11H13N3O,能作為多巴胺受體D2的選擇性完全激動劑[1],1997年為帕金森氏病和不寧腿綜合症研發[2][3]。
參考文獻
- ^ McCall RB, Lookingland KJ, Bédard PJ, Huff RM. Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. September 2005, 314 (3): 1248–56. PMID 15980060. S2CID 9835081. doi:10.1124/jpet.105.084202.
- ^ Romero AG, et al. Synthesis of the selective D2 receptor agonist PNU-95666E from D-phenylalanine using a sequential oxidative cyclization strategy. Journal of Organic Chemistry. 1997; 62(19):6582.
- ^ Weber M, Chang WL, Breier MR, Yang A, Millan MJ, Swerdlow NR. The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. European Neuropsychopharmacology. March 2010, 20 (6): 421–425. PMC 2864324 . PMID 20346635. doi:10.1016/j.euroneuro.2010.02.011.
這是一篇與化學相關的小作品。您可以透過編輯或修訂擴充其內容。 |